Recall report: Eli Lilly pulls diabetes emergency kit after manufacturing mishap
A diabetes injection kit from Eli Lilly has been recalled after reports that the vial of glucagon was in the form of a liquid instead of powder, the FDA says.
The mixup has been attributed to the manufacturing process, the company said. Using liquid glucagon instead of the powder could fail to treat severe low blood sugar, due to a loss of potency. If not reversed, extreme low blood sugar can lead to neurological damage, seizures, and even death if left untreated.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
